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Abstract: A high consumption of fat and simple sugars, especially fructose, has been related to the
development of insulin resistance, but the mechanisms involved in the effects of these nutrients
are not fully understood. This study investigates the effects of a Western-type diet and liquid
fructose supplementation, alone and combined, on insulin signalling and inflammation in low-density
lipoprotein (LDL) receptor-deficient mice (LDL-R−/−). LDL-R−/− mice were fed chow or Western
diet ±15% fructose solution for 12 weeks. Plasma glucose and insulin, and the expression of genes
related to inflammation in the liver and visceral white adipose tissue (vWAT), were analysed. V-akt
murine thymoma viral oncogene homolog-2 (Akt) activation was measured in the liver of the mice
after a single injection of saline or insulin. None of the dietary interventions caused inflammation
in vWAT, whereas the Western diet induced hepatic inflammation, which was further enhanced by
liquid fructose, leading also to a significant increase in fibrogenesis markers. However, there was no
change in plasma glucose or insulin, or insulin-induced Akt phosphorylation. In conclusion, hepatic
inflammation and fibrogenesis markers induced by a Western diet supplemented with liquid fructose
in LDL-R−/− mice are not associated with a significant impairment of hepatic insulin signalling.
Keywords: simple sugars; high-fat diet; adipose tissue; inflammasome; metabolism
1. Introduction
Unhealthy nutritional habits such as the excessive consumption of fat and refined sugars, together
with a sedentary way of life, are linked to metabolic alterations including non-alcoholic fatty liver
disease (NAFLD)—an array of conditions ranging from simple steatosis to steatohepatitis. NAFLD
is strongly associated with insulin resistance (IR). However, the role of hepatic lipid accumulation
and inflammation in the alterations of insulin signalling which will lead to IR is not fully understood.
For example, although in animal models hepatic steatosis has been generally linked to the development
of IR, this association is not so straightforward in the studies in which adiposity and body weight are
not affected [1]. On the other hand, inflammation has been proposed as the link between NAFLD and
IR, as several murine models in which components of the nuclear factor κ B (NFκB) inflammatory
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pathway are constitutively activated or deleted show that increased hepatic inflammation correlates
with an increase in IR [2] and, conversely, a reduction in hepatic inflammation improves hepatic insulin
sensitivity [3–5]. However, the evidence is not so clear, as other murine models show a dissociation
between inflammation in the liver and IR [6–11]. For example, mice with a gain-of-function mutation
in tumour necrosis factor receptor 1 display hepatic inflammation, but systemic and hepatic IR are not
affected and adipose tissue inflammation is not observed [10].
The food constituents that have been linked to the development of metabolic disturbances such
as NAFLD and IR include simple sugars, especially fructose. Our research group has shown that
liquid fructose supplementation in female rats fed a standard chow diet (two weeks to two months)
induces glucose intolerance and IR [12–15]. However, unhealthy human dietary patterns frequently
include not only excessive added sugars, but also excessive fat intake, particularly saturated fats [16].
For this reason, in a recent publication we explored the effects of liquid fructose supplementation to
C57BL/6N mice in two different solid diets, a standard rodent chow and a Western-type rodent chow
rich in saturated fat, refined carbohydrates and cholesterol [17]. Our results showed that in this model
liquid fructose supplementation increased liver triglyceride and cholesterol levels and diminished
whole-body insulin sensitivity only when it was combined with a Western-type diet; however, these
effects were not associated with a clear inflammatory reaction in the liver [17]. We also studied the
effects of these diets on the development of aortic atherosclerotic lesions in low-density lipoprotein
(LDL) receptor-deficient (LDL-R−/−) mice [18]. As it has been shown that the LDL-R−/− mouse is
a good model for studying the progression from steatosis to inflammation in the liver [19], it can
be helpful to better understand the relationship between hepatic lipid accumulation, inflammation
and IR. Here, we investigate the effects on insulin signalling and inflammation of liquid fructose
supplementation and a Western-type diet, alone and combined, using samples from our previous
study conducted on LDL-R−/− mice [18].
2. Materials and Methods
2.1. Animals and Diets
The animal experimental protocols were described in our previous publication [18]. Briefly,
male LDL-R−/− mice were randomly assigned to four groups (n = 10/group): 1. Control group
(CT), which was fed a standard rodent diet (2018 Teklad Global 18% Protein, Envigo, Barcelona,
Spain) without any supplementary sugar; 2. Fructose-supplemented group (F), which received the
same standard diet supplemented with 15% weight/volume fructose in drinking water; 3. Western
group (W), which was fed a Western-type diet (D12079B Open Source Diets, Research Diets Inc.,
New Brunswick, NJ, USA) without any supplementary sugar; 4. Western plus fructose group
(WF), which received the Western-type diet supplemented with 15% weight/volume fructose in
drinking water. The composition of control and Western-type diets was as detailed previously [18].
After 12 weeks, the animals were fasted for 2 h and blood was obtained from the tail vein to determine
glucose concentrations. Six animals from each group were then euthanized under intraperitoneal
ketamine (100 mg/kg)/xylazine (10 mg/Kg) anaesthesia. Blood samples were obtained by intracardiac
puncture, collected in microtubes (Sarstedt AG & Co., Nümbrecht, Germany), and plasma was obtained
by centrifugation and stored at −80 ◦C until use. Liver and visceral white adipose tissue (vWAT)
was excised, immediately frozen in liquid N2 and stored at −80 ◦C until use. The remaining animals
(n = 4/group) were used to study insulin signalling in the liver. To this end, mice were fasted for
12 h, anaesthetised with ketamine:xylazine, as described above, and intraperitoneally injected with
0.15 units of insulin/g body weight (Humulina® Regular, Lilly, Madrid, Spain). Fifteen minutes later
the livers were obtained, frozen in liquid N2 and stored at −80 ◦C.
All procedures were conducted in accordance with the guidelines established by the University
of Barcelona’s Bioethics Committee, as stated in Law 5/1995, of 21 July, from the Catalan government
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(approval code 6078). These guidelines adhere to Directive 2010/63/EU of the European Parliament
on the protection of animals used for scientific purposes.
2.2. Blood and Plasma Analysis
Blood glucose levels were measured using an Accutrend® Plus system glucometer (Cobas, Roche
Farma, Barcelona, Spain). Insulin concentration in plasma was determined using an ELISA kit
(Millipore, Billerica, MA, USA). Whole-body insulin sensitivity was estimated by calculating the
Insulin Sensitivity Index (ISI) [20], and the HOMA-IR [21]. Alanine aminotransferase (ALT) activity in
plasma samples was determined using an ALT/GPT Spinreact kit (Spinreact, Girona, Spain), based
on the spectrophotometric measurement of the rate of reduction in NADH levels. To determine
lipopolysaccharide-binding protein (LBP) levels, we used an ELISA kit from Hycult Biotech (Uden,
The Netherlands).
2.3. Histological Studies
Paraffin-embedded liver sections were stained with hematoxylin and eosin to assess necrosis
and with Masson’s trichrome acid to determine the degree of fibrosis. Images were acquired with
an Olympus BX43 microscope (Olympus Iberia, Barcelona, Spain) and a pathologist blinded to the
treatment groups performed the histological analysis at BioBanc (Banc de tumors-IDIBAPS, Barcelona,
Spain). Necrosis was scored as 0 (absent), 1 (<1%), 2 (<5%), 3 (<10%) or 4 (≥10%).
Fibrosis was categorised as 0 (no fibrosis), 1 (portal or sinusoidal fibrosis without septa), 2 (portal
or sinusoidal fibrosis with rare septa), 3 (abundant septa without cirrhosis) or 4 (cirrhosis).
2.4. RNA Preparation and Analysis
Total RNA was isolated by using Trizol® Reagent (Invitrogen, Carlsbad, CA, USA), in accordance
with the manufacturer’s instructions. Specific mRNAs were assessed by real-time reverse transcription
polymerase chain reaction (RT-PCR), using SYBR Green PCR Master Mix, specific primers and the
Applied Biosystems StepOnePlus sequence detection system (Applied Biosystems, Foster City, CA,
USA). TATA box-binding protein (TBP) was used as an internal control. Primer sequences and PCR
product length are listed in Supplemental Table S1.
2.5. Western Blot Analysis
Total protein extracts from liver were obtained by the Helenius method [22], and protein
concentrations were determined by the Bradford method [23]. Thirty micrograms of protein extracts
were subjected to SDS-polyacrylamide gel electrophoresis. The protein fractions were then transferred
to Immobilon polyvinylidene difluoride transfer membranes (Millipore, Billerica, MA, USA), blocked
for 1 h at room temperature with 5% non-fat milk solution in 0.1% Tween-20-Tris-Buffered Saline
(TBST), and incubated as described previously [24]. Detection was performed using the ECL
chemiluminescence kit for HRP (Amersham GE Healthcare Europe GmbH, Barcelona, Spain).
To confirm the uniformity of protein loading, blots were incubated with β-tubulin antibody
(Sigma-Aldrich, St. Louis, MO, USA) as a control. Primary antibodies for phosphorylated and
total Akt and IκBα were supplied by Cell Signaling Technology (Danvers, MA, USA) and those for
IRS-2 and phosphorylated and total IRβ were obtained from Santa Cruz Biotechnologies (Dallas, TX,
USA). The antibody against phosphorylated IRS-2 was from Abcam (Cambridge, UK).
2.6. Statistical Analysis
The results are expressed as the mean of n values ± SEM. Plasma samples were assayed in
duplicate. Significant differences between the values from the CT, F and W groups were established by
one-way ANOVA and Šidák’s post-hoc test for selected comparisons; significant differences between
the values from the W and WF groups were established by the unpaired t-test (GraphPad Software
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V6, La Jolla, CA, USA). When variance was not homogeneous, a non-parametric test was performed.
The correlations between liver total cholesterol content and inflammation-related parameters were
examined by two-tailed Pearson or Spearman Correlation analyses for data which follow a Gaussian
distribution or not, respectively. The level of statistical significance was set at p ≤ 0.05.
3. Results
3.1. Western Diet ± Liquid Fructose Supplementation Does Not Trigger Visceral White Adipose Tissue
Inflammation in LDL-R−/− Mice
Zoometric parameters and liver lipid content in the animals used in the present study were
previously reported [18], and are shown in Supplemental Table S2. Mice fed a Western-type diet
(W group) showed an increase in body weight at the end of the study compared to controls (C),
and the addition of liquid fructose (WF group) further increased final body weight. Importantly, liver
and vWAT weights were only significantly increased in the WF group compared to the W group,
despite the total amount of calories ingested by the mice from these groups were almost identical.
Using vWAT samples of LDL-R−/− mice from the different dietary groups, we examined the
expression of several pro-inflammatory molecules (Figure 1). The mRNA expression of toll-like
receptor 4 (tlr4), which plays an essential role in the induction of pro-inflammatory cytokines in
adipocytes, showed no differences among the groups. Similarly, the mRNA levels of the adaptor
protein myeloid differentiation factor-88 (myd88) remained unaffected. In accordance with the lack of
activation of the TLR4 pathway, the expression of the inflammatory cytokine tumour necrosis factor α
(tnfα) was not significantly altered in vWAT in any of the dietary groups. C-C chemokine receptor
type 2 (ccr2), which is involved in monocyte chemotaxis, showed a significant increase in the WF group
compared to the W group (p < 0.01). However, the mRNA levels of monocyte chemoattractant protein-1
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Figure 1. Bar plots showing the relative levels of specific mRNAs of pro-inflammatory molecules
from Control (CT, mice fed standard solid-chow), Fructose (F, mice fed standard solid-chow plus a
15% fructose solution ad libitum), Western (W, mice fed Western solid-chow), and Western + Fructose
(WF, mice fed Western solid-chow plus a 15% fructose solution ad libitum), represented as mean (a.u.,
arbitrary units) ± SEM of five different visceral adipose tissue samples. ## p < 0.01 vs. W values.
3.2. A Western-Type Diet Induces Hepatic Inflammation and Liquid Fructose Supplementation Enhances
This Effect
In contrast to the lack of a clear inflammatory response in vWAT, the expression of most of the
inflammatory markers determined in the liver was significantly increased by the Western-type diet
alone and combined with liquid fructose supplementation (Figure 2). Thus, the expression of tlr4 was
induced by the Western diet (1.9-fold increase in W vs. CT group, p < 0.01), and supplementation
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with liquid fructose in this diet further enhanced the effect (2.3-fold increase in WF vs. W group,
p < 0.01), although myd88 mRNA levels remained unaffected. In accordance with tlr4 induction, the
mRNA level of the pro-inflammatory cytokine tnfα was increased in W compared to CT (2.5-fold,
p < 0.05), and further induced after the Western diet was supplemented with fructose (3.3-fold increase
in WF vs. W group, p < 0.01). Regarding the expression of genes related to monocyte recruitment and
macrophage accumulation, our results showed no significant modification in the expression of ccr2,
and a marked increase in the mRNA of mcp-1 only in the WF group compared to W (8.1-fold, p < 0.01),
whereas the expression of the macrophage marker f4/80 was increased by the Western diet and further
increased by fructose supplementation in this diet (1.4-fold, p < 0.05 W vs. CT and WF vs. W).
Given the inflammatory response observed in the liver, we assessed the involvement of
the inflammasome in this process. To this end, the mRNA levels of several components of the
nucleotide-binding domain, leucine-rich-containing family, pyrin domain-containing-3 (NLRP3)
inflammasome were examined. As shown in Figure 3A, the mRNA expression of nlrp3 and
caspase-1 were significantly higher in the WF group compared to the W group (2.5-fold, p < 0.01
and 1.8-fold, p <0.001, respectively). Similarly, the mRNA expression of the adaptor molecule asc
(apoptosis-associated speck-like protein containing a caspase-recruitment domain) was increased by
the Western-type diet (1.3-fold, p < 0.05) and further enhanced by the addition of fructose to this diet
(1.5-fold increase in WF vs. W group, p < 0.01).
One of the pathways that initiates inflammasome activation is mediated by microbial signals,
such as lipopolysaccharide (LPS), which upregulate NLRP3 expression through nuclear factor κB
(NFκB) [25]. Plasma level of LPS-binding protein (LBP), a biomarker of circulating LPS, was unaffected
by fructose supplementation, but increased in the W group compared to the CT group (3-fold, p < 0.05)
(Figure 3B). To determine NFκB activity, we measured the amount of phosphorylated inhibitor of κB
(p-IκB), as the classical pathway of NFκB activation involves IκB phosphorylation and degradation,
which favors NF-κB nuclear translocation and transcriptional activity. Our results show that p-IkB
levels were increased significantly in the WF group compared to W (Figure 3C).
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Figure 2. Bar plots showing the relative levels of specific mRNAs of pro-inflammatory molecules
from Control (CT, mice fed standard solid-chow), Fructose (F, mice fed standard solid-chow plus a
15% fructose solution ad libitum), Western (W, mice fed Western solid-chow), and Western+Fructose
(WF, mice fed Western solid-chow plus a 15% fructose solution ad libitum), represented as mean (a.u.,
arbitrary units) ± SEM of five different liver samples. * p < 0.05, ** p < 0.01 vs. CT values; # p < 0.05,
## p < 0.01 vs. W values.
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Plasma  ALT  activity, which  is  commonly  used  to monitor  liver  injury,  showed  a marked 
increase  in  the WF  group  compared  to  the W  group  (6.8‐fold,  p  <  0.01,  Figure  4A),  although 
hematoxylin and eosin staining did not reveal apparent necrosis in any of the groups (Figure 4B,C). 
Then, we measured the expression of factors related to fibrogenesis key events such as stellate 
cell activation and matrix deposition. The hepatic mRNA  levels of  transforming growth  factor  β 
(tgf‐β) and tissue inhibitor of metalloproteinase 1 (timp‐1) were markedly and significantly increased 
only  in  the WF  group,  compared  to  the W group  (Figure  4D,E). Consistent with  this  induction, 
hepatic collagen α1 (collα1) mRNA levels were markedly increased only in the WF mice (Figure 4F). 
We then assessed the degree of hepatic fibrosis by examining the Masson’s trichrome‐stained liver 
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complex from Control (CT, mice fed standard solid-chow), Fructose (F, mice fed standard solid-chow
plus a 15% fructose solution ad libitum), estern ( , mice fed estern solid-chow), and estern +
Fructose (WF, mice fed Western solid-chow plus a 15% fructose solution ad libitum), represented as
mean (a.u., arbitrary units)± SEM of five different liver samples; (B) Plasma level of lipopolysaccharide
(LPS)-binding protein represented as mean (µg/mL) ± SEM of five to six different plasma samples
obtained from CT, F, W and WF groups; (C) Western-blot of phosphorylated and total IκBα in liver
samples obtained from CT, F, W and WF groups. Representative bands corresponding to three different
mice in each group are shown; bar plots show the level of the phosphorylated protein expressed as
the mean (a.u., arbitrary units) ± SEM of the values obtained from three to four animals. * p < 0.05 vs.
CT values; # p < 0.05, ## p < 0.01, ### p <0.001 vs. W values.
3.3. Addition of a Liquid Fructose Supple ent to a estern-Type iet Increases Fibrogenesis arkers in the
Liver of L L-R−/− Mice
Plas a LT activity, which is commonly used to monitor liver injury, showed a marked increase
in the WF group compared to the W group (6.8-fold, p < 0.01, Figure 4A), although hematoxylin and
eosin staining did not reveal apparent necrosis in any of the groups (Figure 4B,C).
Then, e easured the expression of factors related to fibrogenesis key events such as stellate cell
activation and matrix deposition. The hepatic mRNA levels of transforming growth factor β (tgf-β)
and tissue inhibitor of metalloproteinase 1 (timp-1) were markedly and significantly increased only
in the WF group, compared to the W group (Figure 4D,E). Consistent with this induction, hepatic
collagen α1 (collα1) mRNA levels were markedly increased only in the WF mice (Figure 4F). We then
assessed the degree of hepatic fibrosis by examining the Masson’s trichrome-stained liver sections.
As shown in Figure 4G,H, none of the diets caused overt liver fibrosis; the semi-quantitative analysis
of fibrosis scores indicated that only in the fructose-supplemented groups there were 50%–70% of mice
with score 1, and in the WF group there was one animal which reached grade 2.
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3.4. Fructose Supplementation and a Western Diet Reduce Basal Insulin Receptor Substrate-2 (IRS-2)
Expression but Do Not Impair Insulin-Stimulated Akt Phosphorylation in the Liver of LDL-R−/− Mice
Plasma glucose and plasma insulin levels remained essentially unaffected by the different dietary
interventions (Figure 5A,B). When we calculated the insulin sensitivity index (ISI), we observed a
non-significant trend to reduction in the WF group (Figure 5C). In addition, we calculated another
surrogate index of insulin sensitivity, the HOMA-IR, and the results also pointed to lower insulin
sensitivity, especially in the WF group compared to W, although it did not reach statistical significance
(1.7 ± 0.6, 4.3 ± 3.6, 3.0 ± 1.1 and 5.9 ± 1.2, expressed as mean ± SEM, for C, F, W and WF groups).
Thus, we wondered whether the establishment of an inflammatory and pro-fibrotic status in the liver
could alter insulin signalling in this tissue. The basal expression of IRS-2, one of the main transducers of
the insulin signal in the liver, was reduced in F and W groups vs. CT, and further diminished in WF vs.
W (Figure 5D). We also determined the amount of IRS-2 phosphorylated at Ser731, as phosphorylation
at this position has been related to impaired insulin signal transduction [26]. Our results showed
significant increases in IRS-2 phosphorylation status in the W group compared to the CT group and in
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Figure 5. Insulin receptor signalling under basal conditions. Glucose (A) and insulin (B) plasma levels
from Control (CT, mice fed standard solid-chow), Fructose (F, mice fed standard solid-chow plus a
15% fructose solution ad libitum), Western (W, mice fed Western solid-chow), and Western + Fructose
(WF, mice fed Western solid-chow plus a 15% fructose solution ad libitum), expressed as mean ± SEM
of 9–10 different samples; (C) Insulin Sensitivity Index (ISI), calculated as [2/(blood insulin (nM)
× blood glucose (µM) + 1]; Western-blot of total and phosphorylated IRS-2 (D,E) proteins in liver
samples obtained from the different experimental groups under basal conditions. Representative
bands corresponding to three different mice in each group are shown; bar plots show the level of total
IRS-2 expressed as the mean (a.u., arbitrary units) ± SEM of the values obtained from three to four
animals, and the ratio between phosphorylated and total IRS-2. * p < 0.05 and ** p < 0.01 vs. CT values;
# p < 0.05 vs. W values.
To further explore whether hepatic insulin sensitivity was impaired, we injected insulin
(0.15 units/g body weight) in a subset of rats and 15 minutes later we assessed the phosphorylation
status of several molecules related to insulin signalling: the beta subunit of the insulin receptor (IR-β),
Nutrients 2017, 9, 278 9 of 15
IRS-2 and Akt. As shown in Figure 6A, insulin-induced IR-β phosphorylation tended to be lower in
W and WF groups, but these differences did not reach significance. On the other hand, under acute
insulin-stimulated conditions, neither the phosphorylation of IRS-2 at Ser731, nor Akt phosphorylation
at both Thr308 and Ser473 positions were modified by any of the dietary interventions (Figure 6B–D).Nutrients 2017, 9, 278  9 of 15 
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Figure 6. Insulin receptor signalling after an acute insulin challenge. Western-blot of total and
phosphorylated IR-β (A), IRS-2 (B,C) and Akt (D) proteins in liver samples obtained from the
different experimental groups, after exogenous insulin administration (0.15 units/g body weight).
Representative bands corresponding to three different ice in each group are shown; bar plots show
the lev l of the proteins xpr ssed as the m an ( .u., arbitrary units)± SEM of the values obtaine from
three t four animals. For IRS-2, as the corresponding total pr ein levels vary significantly between
groups, th bar plot s ows the ratio between phosphorylated and tot l pr tein levels.
4. Discussion
Here we show that consumption of a Western-type diet for 12 weeks causes an inflammatory
reaction in the liver of male LDL-R−/− mice that is exacerbated by 15% w/v liquid fructose
supplementation, which also increases fibrogenesis markers. However, vWAT is not inflamed and
hepatic insulin-induced Akt phosphorylation is not hampered, despite a clear reduction in basal
IRS-2 levels.
In this study we used LDL-R−/− mice, a model of diet-i duced atheroscl rosis that is also suitable
for investigating the progress from hepatic steatosis to non-alcoholic steatohepatitis (NASH) [19].
We fed these mice either a standard rodent chow diet or a Western-type diet rich in cholesterol (0.21%),
saturated fat (21%) and sucrose (34%) to provide a high fructose intake [18]. A high level of fructose in
the diet is required to mimic all human NASH features in rodents and is typical of the diet consumed
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by humans with NASH [27]. Moreover, we added liquid fructose to both diets (15% w/v), since
unhealthy human diets are also characterised by a high intake of beverages sweetened with sucrose or
high-fructose corn syrup (both of which contain fructose), and this has been linked to the acquisition
of NAFLD and its progression to NASH and hepatic fibrosis [28,29].
Bieghs et al. [19] showed that LDL-R−/− mice develop sustained hepatic inflammation upon high
cholesterol feeding due to the uptake of oxidized low-density lipoproteins through the CD36 receptor.
Moreover, it has been shown that hepatic cholesterol accumulation is one of the main drivers of hepatic
inflammation in LDL-R−/− mice [30]. In the present study, only mice with the highest liver cholesterol
content (W and WF groups) show a clear inflammatory response in this tissue, and the response is
more intense in the WF group (Supplemental Table S2 and Figure 2). This is in agreement with our
previous observation of increased CD36 mRNA expression in WF-LDL-R−/− mice [18]. In contrast,
our recent study performed in wild type C57BL/6N mice, showed no signs of hepatic inflammation
despite a significant increase in hepatic cholesterol deposition in W and WF groups [17]. To compare
the hepatic cholesterol deposition between wild type and knockout mice, we used data from [17,18],
and expressed them as mg of cholesterol per gram protein. This is more accurate for comparison, due
to the significant increase in liver weight observed in LDL-R−/− mice from the WF group, but not in
wild-type mice. As shown in Figure 7A, the amount of cholesterol per gram of liver protein in control
LDL-R−/− mice is already as high as the amount observed in wild type mice fed with the Western-type
diet, and W and WF LDL-R−/− mice more than doubled the hepatic cholesterol compared to the same
dietary groups in wild type mice. The presence of hepatic inflammation in LDL-R−/− but not in wild
type mice may thus be related to the larger cholesterol accumulation in the liver of knockout mice
even when fed a healthy control diet. In support of this hypothesis, we found significant correlations
between total cholesterol content in the livers of LDL-R−/− mice and the hepatic expression of the
inflammatory markers tlr4, tnfα, mcp-1, f4/80, as well as the inflammasome components nlrp3, caspase-1
and asc (Figure 7B–H).
However, other pathways besides cholesterol accumulation may be involved in the onset of
hepatic inflammation and its exacerbation by fructose addition. It has been reported that liquid
fructose supplementation (30% w/v) in mice increases intestinal permeability and thus allows bacterial
endotoxins to enter portal blood, which then leads to the development of liver TLR4-mediated
inflammation [31,32]. Our results show that liquid fructose supplementation in the LDL-R−/− model
does not seem to increase blood endotoxins, as revealed by unchanged plasma levels of LBP, a
biomarker of circulating lipopolysaccharide (Figure 3B). This lack of effect can be attributed to the
use of a different strain or the lower concentration of fructose solution used in our study (15 vs. 30%
w/v). However, we show here that plasma LBP increases significantly in mice fed a Western-type diet
compared to the chow-fed mice (Figure 3B). This suggests that the increase in intestinal permeability to
bacterial toxins in our model may be caused by some component of the Western diet. Thus in WF mice,
which ingest a smaller amount of solid food than the W group [18], the amount of plasma LBP is also
somewhat reduced, albeit not significantly (Figure 3B). Gut-derived bacterial components act as a first
signal to prime the inflammasome, through binding to TLRs and subsequent NFκB activation leading
to the upregulation of NLRP3 transcription [25]. In accordance with the higher LBP levels, our results
show that the Western-type diet increases tlr4 mRNA expression and that fructose supplementation
enhances this effect. However, significant NFκB activation (Figure 3C) and nlrp3 induction (Figure 3A)
are only observed in the WF group, suggesting that fructose or the Western-type diet alone do not
suffice to fully prime the inflammasome. Activation of the TLR4-NFκB pathway enables a second,
non-microbial-derived signal to activate the NLRP3 inflammasome [25]. It has been shown that
cholesterol crystals activate the NLRP3 inflammasome [33], and as we have mentioned before the
highest hepatic cholesterol levels are only achieved when fructose is added to a Western-type diet.
Thus, it is plausible to suggest that fructose added to a healthy dietary substrate is not potent enough
to activate the inflammasome, but it may act as a second step contributing to full inflammasome
activation in the WF group.
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Figure 7. (A) Liver cholesterol levels from wild-type (WT) and LDL-R−/− mice fed standard solid-chow
(CT), standard solid-chow plus a 15% fructose solution ad libitum (F), Western solid-chow (W), and
Western solid-chow plus a 15% fructose solution ad libitum (WF), expressed as mean ± SEM of
9–10 animals; Data were obtained from [17,18]. Correlation between liver cholesterol content and
mRNA expression of pro-inflammatory molecules including: (B) toll-like receptor 4 (tlr4); (C) tumor
necrosis factor (TNF-α); (D) m ocyte chemoattractant protein-1 (mcp-1); (E) f4/80; (F) NLR family
pyrin domain con a ing 3 ( lrp3); (G) caspase-1 (casp1) and (H) apoptosis-associated speck-like protein
containing a caspase-recruitment domain (asc). Statistic l analysis was performed using two tailed
Pearson or Spearman correlation. R indicates correlation coefficient.
Nutrients 2017, 9, 278 12 of 15
Inflammasome activation leads to the induction of mcp-1 and thus to the recruitment of
inflammatory cells into the damaged tissue [25]. Accordingly, although mcp-1 and f4/80 mRNA
levels are gradually increased by the dietary interventions, and the increase is maximal in the group in
which inflammasome is fully activated, i.e., the WF group (Figure 2). Inflammasome activation also
stimulates stellate hepatic cells through increased IL-1 secretion and leads to fibrosis [25]. This is also
consistent with our results, since the expression of the critical inducers of fibrogenesis (tgfβ and timp-1),
as well as the expression of one of the predominant collagens in the fibrotic liver (collα1), are only
significantly increased in livers from the WF group (Figure 4D–F). Liver fibrosis is a dynamic process,
where progression to advanced fibrotic stages is characterized by increased synthesis and decreased
degradation of extracellular matrix (ECM) proteins, whereas the opposite may lead to regression or
reversal [34,35]. Several studies in humans and animal models suggest a prominent role for TIMP-1 in
this process, as TIMP-1 up-regulation by inflammatory cytokines, especially TGFβ, shifts the balance
toward ECM synthesis and fibrogenesis [35,36]. TIMP-1 not only prevents the degradation of the
accumulated ECM by blocking the function of matrix metalloproteases, thus opposing to fibrosis
reversal, but also inhibits the apoptosis of activated hepatic stellate cells, the main cellular source
of type I collagen [37]. Thus, although histological signs of overt hepatic fibrosis are still absent in
our model (Figure 4G,H), the marked induction of TIMP-1 in the WF group suggest that with longer
exposure to this WF diet fibrosis would continue unopposed, leading to progression to advanced
fibrotic stages.
The presence of hepatic steatosis [18] and the inflammatory and pro-fibrogenic status in the liver
of LDL-R−/− mice caused by the combined effects of fructose and the Western diet prompted us to
examine the effects of the dietary interventions on the hepatic insulin signalling cascade. Although
plasma glucose and insulin levels do not vary significantly between groups, whole-body insulin
sensitivity (measured by the ISI) tends to decrease in the WF group. Moreover, under basal conditions,
the amount of total IRS-2 is reduced and phosphorylation of IRS-2 at Ser731 is increased across
the different dietary groups, which suggest an impairment of hepatic insulin receptor signalling
cascade (Figure 5). However, after an insulin challenge total IRS-2 expression is not reduced and its
phosphorylation status does not vary significantly. In addition, the phosphorylation of Akt at Thr308
and Ser473, which lead to full Akt activation after insulin stimulation [38–40], is not impaired by any of
the dietary regimes (Figure 6). These results suggest that despite there is some degree of impairment in
insulin receptor signalling under basal conditions, when insulin levels are high this deficit is overcome
and signal transduction proceeds correctly.
Our results showing inflammation and signs of progression to fibrosis contrasts with the prevalent
theory that links these phenomena with IR [2–5]. However, it has been suggested that insulin sensitivity
is not reduced when the inflammation is restricted to the liver compartment and does not affect adipose
tissue [1,11,41]. Our results are in accordance with this hypothesis, as LDL-R−/− mice show no signs
of inflammation in vWAT (Figure 1), whereas in our previous study in wild type mice we observed
inflammation in vWAT but not in the liver, and whole-body insulin sensitivity was significantly
reduced [17].
In contrast to our results, Subramanian et al. [30] found a marked inflammatory reaction in
epididymal adipose tissue from LDL-R−/− mice that were fed a diabetogenic diet with 0.15%
cholesterol, which was linked to whole-body IR. Although the amount of cholesterol in the
Western-type diet was even greater in our study (0.21%), we used a shorter feeding period (12 weeks
instead of 24 weeks). Long-term studies (5.5 months) also show that a Western-type diet similar to the
one used in the present study causes IR with hyperglycaemia and hyperinsulinemia [42]. Therefore,
we cannot rule out the possibility that longer exposure to the Western-type diet, with or without liquid
fructose supplementation, could also induce adipose tissue inflammation and IR. However, in a recent
study with a relatively short duration (16–20 weeks), LDL-R−/− mice fed diets that provided more
calories from fat (58%–60%) and fewer calories from carbohydrate (20%–28%) than our Western-type
diet (40 kcal% fat and 43 kcal% carbohydrate) showed inflammation in both liver and adipose tissue,
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accompanied by IR and impaired glucose tolerance [43]. Therefore, both the duration of the study and
the type of nutrients provided by the diet determine the metabolic response.
Taken together, our results suggest that liquid fructose supplementation in a Western-type diet in
LDL-R−/− mice aggravates the inflammatory response in the liver and initiates fibrogenesis, but the
lack of inflammation in vWAT probably delays the manifestation of glucose intolerance and impaired
hepatic insulin signalling.
Supplementary Materials: The following are available online at http://www.mdpi.com/2072-6643/9/3/278/s1,
Table S1: Primers used for RT-PCR., Table S2: Zoometric parameters of LDLR−/− mice exposed to four different
dietary regimes.
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